Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company dedicated to developing treatments for patients with RAS/MAPK pathway-driven cancers, will be featured in a fireside chat at the Bank of America Securities 2023 Health Care Conference in Las Vegas, NV.
On Tuesday, May 9, 2023, at 2:20 pm Pacific Time, Erasca’s management team will discuss the company’s progress and answer questions from investors. In addition, the management team will also be available for private one-on-one meetings.
At Erasca, we are on a mission to erase cancer. We are a clinical-stage precision oncology company pioneering the discovery, development, and commercialization of therapies for RAS/MAPK pathway-driven cancers.
Our team consists of leading experts in precision oncology and RAS targeting, and our scientific advisory board includes some of the world’s foremost authorities in the RAS/MAPK pathway. With the deepest RAS/MAPK pathway-focused pipeline in the industry, we are determined to make our bold mission a reality and eradicate cancer.